These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 9472703

  • 1. Analysis of two inbred strains of mice derived from the SENCAR stock with different susceptibility to skin tumor progression.
    Stern MC, Gimenez-Conti IB, Budunova I, Coghlan L, Fischer SM, DiGiovanni J, Slaga TJ, Conti CJ.
    Carcinogenesis; 1998 Jan; 19(1):125-32. PubMed ID: 9472703
    [Abstract] [Full Text] [Related]

  • 2. Dissociation of sensitivities to tumor promotion and progression in outbred and inbred SENCAR mice.
    Gimenez-Conti IB, Bianchi AB, Fischer SM, Reiners JJ, Conti CJ, Slaga TJ.
    Cancer Res; 1992 Jun 15; 52(12):3432-5. PubMed ID: 1375869
    [Abstract] [Full Text] [Related]

  • 3. Genetic analyses of mouse skin tumor progression susceptibility using SENCAR inbred derived strains.
    Stern MC, Benavides F, LaCava M, Conti CJ.
    Mol Carcinog; 2002 Sep 15; 35(1):13-20. PubMed ID: 12203363
    [Abstract] [Full Text] [Related]

  • 4. New strains of inbred SENCAR mice with increased susceptibility to induction of papillomas and squamous cell carcinomas in skin.
    Hennings H, Lowry DT, Yuspa SH, Mock B, Potter M.
    Mol Carcinog; 1997 Sep 15; 20(1):143-50. PubMed ID: 9328445
    [Abstract] [Full Text] [Related]

  • 5. Genetic susceptibility to papilloma progression in SENCAR mice.
    Stern MC, Gimenez-Conti IB, Conti CJ.
    Carcinogenesis; 1995 Aug 15; 16(8):1947-53. PubMed ID: 7634426
    [Abstract] [Full Text] [Related]

  • 6. Changes in protein expression during multistage mouse skin carcinogenesis.
    Rundhaug JE, Gimenez-Conti I, Stern MC, Budunova IV, Kiguchi K, Bol DK, Coghlan LG, Conti CJ, DiGiovanni J, Fischer SM, Winberg LD, Slaga TJ.
    Mol Carcinog; 1997 Sep 15; 20(1):125-36. PubMed ID: 9328443
    [Abstract] [Full Text] [Related]

  • 7. Tumor progression in Sencar mouse skin as a function of initiator dose and promoter dose, duration, and type.
    Ewing MW, Conti CJ, Kruszewski FH, Slaga TJ, DiGiovanni J.
    Cancer Res; 1988 Dec 15; 48(24 Pt 1):7048-54. PubMed ID: 3142681
    [Abstract] [Full Text] [Related]

  • 8. SENCAR mouse skin tumorigenesis model versus other strains and stocks of mice.
    Slaga TJ.
    Environ Health Perspect; 1986 Sep 15; 68():27-32. PubMed ID: 3096709
    [Abstract] [Full Text] [Related]

  • 9. Development and initial characterization of several new inbred strains of SENCAR mice for studies of multistage skin carcinogenesis.
    Coghlan LG, Gimenez-Conti I, Kleiner HE, Fischer SM, Rundhaug JE, Conti CJ, Slaga TJ, DiGiovanni J.
    Carcinogenesis; 2000 Apr 15; 21(4):641-6. PubMed ID: 10753198
    [Abstract] [Full Text] [Related]

  • 10. FVB/N mice: an inbred strain sensitive to the chemical induction of squamous cell carcinomas in the skin.
    Hennings H, Glick AB, Lowry DT, Krsmanovic LS, Sly LM, Yuspa SH.
    Carcinogenesis; 1993 Nov 15; 14(11):2353-8. PubMed ID: 8242866
    [Abstract] [Full Text] [Related]

  • 11. The suprabasal expression of alpha 6 beta 4 integrin is associated with a high risk for malignant progression in mouse skin carcinogenesis.
    Tennenbaum T, Weiner AK, Belanger AJ, Glick AB, Hennings H, Yuspa SH.
    Cancer Res; 1993 Oct 15; 53(20):4803-10. PubMed ID: 8402665
    [Abstract] [Full Text] [Related]

  • 12. Microsatellite DNA variants between the inbred SENCAR mouse strains.
    Benavides F, Stern MC, Glasscock E, DiGiovanni J, Coghlan LG, Conti CJ.
    Mol Carcinog; 2000 Aug 15; 28(4):191-5. PubMed ID: 10972988
    [Abstract] [Full Text] [Related]

  • 13. Evidence for a common genetic pathway controlling susceptibility to mouse skin tumor promotion by diverse classes of promoting agents.
    DiGiovanni J, Walker SC, Beltran L, Naito M, Eastin WC.
    Cancer Res; 1991 Mar 01; 51(5):1398-405. PubMed ID: 1900038
    [Abstract] [Full Text] [Related]

  • 14. Characterization of skin tumor promotion and progression by chrysarobin in SENCAR mice.
    Kruszewski FH, Conti CJ, DiGiovanni J.
    Cancer Res; 1987 Jul 15; 47(14):3783-90. PubMed ID: 3109733
    [Abstract] [Full Text] [Related]

  • 15. Promoter independence as a feature of most skin papillomas in SENCAR mice.
    Aldaz CM, Conti CJ, Chen A, Bianchi A, Walker SB, DiGiovanni J.
    Cancer Res; 1991 Feb 01; 51(3):1045-50. PubMed ID: 1899044
    [Abstract] [Full Text] [Related]

  • 16. Transplantation analyses of the immunogenicity of epidermal tumors generated in murine skin two-stage carcinogenesis protocols.
    Reiners JJ, Singh KP, Yoon HL, Conti CJ.
    Mol Carcinog; 1997 Sep 01; 20(1):48-57. PubMed ID: 9328435
    [Abstract] [Full Text] [Related]

  • 17. Differential susceptibility to chemically induced thymic lymphomas in SENCARB and SSIN inbred mice.
    Benavides F, Gomez G, Venables-Griffith A, Lambertz I, Flores M, Angel JM, Fuchs-Young R, Richie ER, Conti CJ.
    Mol Carcinog; 2006 Jul 01; 45(7):543-8. PubMed ID: 16479612
    [Abstract] [Full Text] [Related]

  • 18. Susceptibility of 129/SvEv mice in two-stage carcinogenesis protocols to 12-O-tetradecanoylphorbol-13-acetate promotion.
    Reiners JJ, Singh KP.
    Carcinogenesis; 1997 Mar 01; 18(3):593-7. PubMed ID: 9067561
    [Abstract] [Full Text] [Related]

  • 19. Increased apoptosis during papilloma development in mice susceptible to tumor progression.
    Stern MC, Durán HA, McKenna EA, Conti CJ.
    Mol Carcinog; 1997 Sep 01; 20(1):137-42. PubMed ID: 9328444
    [Abstract] [Full Text] [Related]

  • 20. Further studies on the influence of initiation dose on papilloma growth and progression during two-stage carcinogenesis in SENCAR mice.
    DiGiovanni J, Walker SE, Aldaz CM, Slaga TJ, Conti CJ.
    Carcinogenesis; 1993 Sep 01; 14(9):1831-6. PubMed ID: 8403206
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.